On October 25th, 2014 we will mark the 20th anniversary of DSHEA (Dietary Supplement Health and Education Act), which has been responsible for revolutionizing the way we market dietary supplement […] Read More >>
Developing new ingredients for a large company like Pharmachem, we’ve had to be responsible and conservative at every turn, working within established guidelines and with excellent people. Safety is always […] Read More >>
After three years as the director of FDA’s division of dietary supplements, Dr. Daniel Fabricant, has rejoined the Natural Products Association (NPA) as its CEO. In his first presentation to […] Read More >>
FDA proposes radical changes to Nutrition Facts label to aid consumers. Proposal currently under consultation, so no changes are required yet. The U.S. Food and Drug Administration (FDA) is proposing […] Read More >>
 Thursday, January 16, 2014 Three Part Webinar Series  Provided by dicentra and Knowledge Bank Foods vs. Dietary Supplements:  Cross Dressing Products  Dear dicentra Subscriber, Jut in time for our upcoming […] Read More >>
Three Part Webinar Series Provided by dicentra and Knowledge Bank Foods vs. Dietary Supplements:  Cross Dressing Products  At SupplySide West this year Daniel Fabricant of the FDA stressed that the […] Read More >>
The proposed Dietary Supplement Labeling Act of 2013 to amend the FFDCA and would require big changes to the industry, if the Act is passed.  On August 1, 2013 the […] Read More >>
A dietary supplement health claim substantiation assessment during product development may help to bring your product to market with ease. Dietary Supplement Health Claim Substantiation Health claim substantiation for your […] Read More >>
DR. MOHAMMAD KHALID, PH.D., B.SC.(HONS) Dr. Khalid is the leading GMP expert at dicentra. He helps dicentra’s clients reach compliance with the FDA GMP Rule for Dietary Supplements (21 CFR […] Read More >>
March 26, 2013: dicentra conducted its first webinar of 2013. Critical American and Canadian updates including FDA’s proposed rules to amend cGMPs for food facilities under FSMA, the FDA’s Draft […] Read More >>
Supplier qualification is a requirement of the regulations, as set out by 21 CFR part 111.75. Setting up a proper supplier qualification program is an essential step in maintaining dietary […] Read More >>
Although rare the FTC and FDA have recently sent a joint warning letter to a company. An FDA warning letter can be scary enough, but a joint warning letter can […] Read More >>
  2012 could have had a profound impact on the dietary supplement industry with the possibility of a new president, the resultant changes at FDA and FTC associated with a […] Read More >>
Topics covered: Canada: Consultations & Regulatory Initiatives Food Safety & Initiatives United States: Proposition 37 – Genetically Engineered Foods, Labeling, Initiative Statute Energy Drink Controversey Status of Draft NDI Guidance [&helli Read More >>
  At the NBJ Summit this summer, Dr. Daniel Fabricant, Ph.D., director of the FDA’s Division of Dietary Supplement Programs, was asked his opinion on the status of the dietary […] Read More >>
August 28, 2012 A Quick Note…. There have been a number of significant developments on the regulatory front for dietary supplements in the United States lately. For example, dietary supplement […] Read More >>
  On July 24, 2012 the FDA issued a Warning letter to United Nutrition Labs for continually failing to comply with current Good Manufacturing Practices (cGMPs) after a thorough on-site […] Read More >>
By Heather VanBlarcom General Counsel & Senior Regulatory Specialist for Dietary Supplements At the NBJ Summit last week in Dana Point, CA, David C. Vladeck, the Director of the Federal […] Read More >>
By: Ashleigh Hampton, MSc Manager, Scientific Affairs Supporting evidence is required by both the Canadian and American regulatory bodies to substantiate marketed health claims. Health Canada reviews the evidence to […] Read More >>
By Heather VanBlarcom General Counsel & Senior Regulatory Specialist for Dietary Supplements On July 16, 2012, the U.S. Food & Drug Administration (FDA) filed an injunction against a New York […] Read More >>